It provides a forum for WHO member states to collaborate in monitoring drug safety. Within the programme, individual case reports of suspected adverse drug reactions are collected.
Originador(es): World Health Organization - WHO, WHO Collaborating Centre for International Drug Monitoring / Uppsala Monitoring Centre - UMC.
Recurso adicionado em:
28/11/2001
Idiomas disponíveis:
Inglês
comments powered by Disqus